You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 27, 2024

CLINICAL TRIALS PROFILE FOR ONCASPAR

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for ONCASPAR

Subscribe to access the full database, or Try a Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00002812 ↗	Combination Chemotherapy in Treating Children With Acute Lymphocytic Leukemia	Completed	National Cancer Institute (NCI)	Phase 3	1996-09-01	RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug and giving the drugs in different combinations may kill more cancer cells. PURPOSE: Randomized phase III trial to compare the effectiveness of standard combination chemotherapy treatment with more intensive combination chemotherapy in treating children with acute lymphocytic leukemia.
NCT00002812 ↗	Combination Chemotherapy in Treating Children With Acute Lymphocytic Leukemia	Completed	Children's Oncology Group	Phase 3	1996-09-01	RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug and giving the drugs in different combinations may kill more cancer cells. PURPOSE: Randomized phase III trial to compare the effectiveness of standard combination chemotherapy treatment with more intensive combination chemotherapy in treating children with acute lymphocytic leukemia.
NCT00005945 ↗	Comparison of Different Combination Chemotherapy Regimens in Treating Children With Acute Lymphoblastic Leukemia	Completed	National Cancer Institute (NCI)	Phase 3	2000-06-01	RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Giving more than one drug may kill more cancer cells. It is not yet known which combination chemotherapy regimen is more effective in treating childhood acute lymphoblastic leukemia. PURPOSE: This randomized phase III trial is comparing different combination chemotherapy regimens to see how well they work in treating children with acute lymphoblastic leukemia.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for ONCASPAR

Condition Name

Chart
Table

Condition Name for ONCASPAR
Intervention	Trials
Acute Lymphoblastic Leukemia	17
Untreated Childhood Acute Lymphoblastic Leukemia	11
Untreated Adult Acute Lymphoblastic Leukemia	9
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for ONCASPAR
Intervention	Trials
Precursor Cell Lymphoblastic Leukemia-Lymphoma	48
Leukemia	48
Leukemia, Lymphoid	47
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for ONCASPAR

Trials by Country

Map
Table

Trials by Country for ONCASPAR
Location	Trials
Canada	144
Australia	60
New Zealand	25
Puerto Rico	14
Switzerland	9
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for ONCASPAR
Location	Trials
Texas	34
California	33
New York	30
Pennsylvania	28
Ohio	28
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for ONCASPAR

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for ONCASPAR
Clinical Trial Phase	Trials
Phase 4	1
Phase 3	20
Phase 2/Phase 3	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for ONCASPAR
Clinical Trial Phase	Trials
Completed	22
Active, not recruiting	12
Recruiting	11
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for ONCASPAR

Sponsor Name

Chart
Table

Sponsor Name for ONCASPAR
Sponsor	Trials
National Cancer Institute (NCI)	33
Children's Oncology Group	16
M.D. Anderson Cancer Center	6
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for ONCASPAR
Sponsor	Trials
Other	46
NIH	33
Industry	16
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.